CADRENAL THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4127 USD | -1.74% |
|
-6.92% | -44.22% |
Chart calendar Cadrenal Therapeutics, Inc.
e8233bf990b3faad4.8N7nl9shHPbEAXSAZKSmYn-VaNcng3u8My_gbNWdKu4.urnU-bdtRYXxdBvYDer8Ehb9JKNs9iKJW1m3WIDSX6ioqNCjsG1op4xmJQ~cbc2f386a35fdd51b4a36a04c04795fd
Upcoming events on Cadrenal Therapeutics, Inc.
Past events on Cadrenal Therapeutics, Inc.
| 09/05/2024 06:30 pm | Q1 2024 Earnings Release |
| 18/04/2024 10:30 pm | Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference |
| 11/03/2024 06:30 pm | Q4 2023 Earnings Release |
| 04/03/2024 | Technology and Heart Failure Therapeutics Conference |
| 01/02/2024 09:30 pm | Lytham Partners Investor Select Conference |
| 05/12/2023 02:30 am | Noble Capital Markets Emerging Growth Equity Conference |
| 09/11/2023 | Q3 2023 Earnings Release |
| 20/10/2023 | Annual General Meeting |
| 17/10/2023 08:00 pm | Lytham Partners Fall Investor Conference - Panel |
| 17/10/2023 04:30 pm | Lytham Partners Fall Investor Conference |
| 11/09/2023 | H.C. Wainwright Global Investment Conference |
| 10/08/2023 06:30 pm | Q2 2023 Earnings Release |
| 05/06/2023 | BIO International Convention |
| 18/05/2023 11:30 pm | Lytham Partners Spring Investor Conference |
| 18/05/2023 06:30 pm | Lytham Partners Spring Investor Conference |
| 10/05/2023 06:30 pm | Q1 2023 Earnings Release |
| 06/02/2023 | BIO CEO and Investor Conference |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -7,63 -7,70 0.9% | -10,1 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -7,63 -7,64 0.15% | -8,22 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -8,36 -7,64 -9.36% | -7,97 |
|
Net income Million USD | Released Forecast Spread | -6,71 | -8,36 -7,64 -9.36% | -7,97 |
|
EPS USD | Released Forecast Spread | -0,85 | -0,62 -0,57 -8.77% | -0,36 |
| Announcement Date | 30/03/23 | 11/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | |
|
EBITDA Million USD | Released Forecast Spread | -1,26 -1,30 2.83% | -1,76 -1,50 -17.08% | -2,10 | -2,90 | -3,40 | |
|
EBIT Million USD | Released Forecast Spread | -1,26 -1,26 -0.26% | -1,76 -1,43 -22.77% | -1,78 | -2,30 | -2,60 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -1,14 -1,17 2.3% | -1,66 -1,32 -26.49% | -1,70 | -2,22 | -2,60 | |
|
Net income Million USD | Released Forecast Spread | -1,04 | -1,14 -1,17 2.3% | -1,66 -1,32 -26.49% | -1,70 | -2,22 | -2,60 |
|
EPS USD | Released Forecast Spread | -0,07 | -0,05 -0,08 37.5% | -0,10 -0,05 -100% | -0,09 | -0,09 | -0,11 |
| Announcement Date | 09/11/23 | 11/03/24 | 09/05/24 | - | - | - |
More events
Past sector events for Cadrenal Therapeutics, Inc.
| Today | SHILPA MEDICARE LIMITED: Q4 2024 Earnings Release |
| Today | ORCHID PHARMA LIMITED: Q4 2024 Earnings Release |
| 22/05/2024 | GLAND PHARMA LIMITED: Q4 2024 Earnings Release |
| 21/05/2024 04:27 pm | ERIS LIFESCIENCES LIMITED: Q4 2024 Earnings Release |
| 21/05/2024 02:30 am | TARO PHARMACEUTICAL INDUSTRIES LTD.: Q4 2024 Earnings Release |
| 17/05/2024 06:22 pm | J. B. CHEMICALS & PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 17/05/2024 01:58 pm | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 15/05/2024 07:35 pm | MANKIND PHARMA LIMITED: Q4 2024 Earnings Release |
| 15/05/2024 11:00 am | DERMAPHARM HOLDING SE: Q1 2024 Earnings Release |
| 15/05/2024 05:10 pm | CRESCO LABS INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CVKD Stock
- Calendar Cadrenal Therapeutics, Inc.
